Back to search

Democritus University of Thrace (DUTH)

Bioavailability and pharmacokinetic evaluation of GnRH conjugates

Abstract

dc:description

Gemcitabine, a drug with established efficacy against a number of solid tumors, has therapeutic limitations due to its rapid metabolic inactivation. The aim of this thesis was the development of an innovative strategy to produce a metabolically stable analogue of gemcitabine that could also be selectively delivered to prostate cancer cells based on cell surface expression of the Gonadotropin Releasing Hormone-Receptor (GnRH-R). The evaluation of conjugated molecules, consisting of gemcitabine linked to a GnRH agonist, is presented along with results in castration resistant prostate cancer models. In vitro cytotoxicity, cellular uptake and metabolite formation of the conjugates were examined in prostate cancer cell lines. Selected conjugates were efficacious in the in vitro assays with one of them, namely GSG, displaying high antiproliferative activity in prostate cancer cell lines along with significant metabolic and pharmacokinetic advantages in comparison to gemcitabine. Finally, treatment of GnRH-R positive xenografted mice with GSG, showed a significant advantage in tumor growth inhibition when compared to gemcitabine.

Degree

thesis:*
Grantor dc:publisher
Democritus University of Thrace (DUTH)
Year dc:date
2014

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Karampelas, Theodoros
  • Καράμπελας, Θεόδωρος

Subjects

dc:subject × 6

Rights

Language dc:language
eng

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/33132

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Karampelas, Theodoros; Καράμπελας, Θεόδωρος. Bioavailability and pharmacokinetic evaluation of GnRH conjugates. Democritus University of Thrace (DUTH), 2014. http://hdl.handle.net/10442/hedi/33132